Department of Gastric Surgery, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, P. R. China.
Department of General Surgery, Weifang People's Hospital, Weifang, P. R. China.
Acta Chir Belg. 2024 Dec;124(6):478-486. doi: 10.1080/00015458.2024.2348256. Epub 2024 May 11.
Despite the increasing use of robotic gastrectomy (RG) as an alternative to laparoscopic gastrectomy (LG) in treating gastric cancer, controversy remains over the advantages of RG compared to LG and there is a paucity of studies comparing the two techniques regarding patient survival.
In this retrospective cohort study, 675 patients undergoing minimally invasive gastrectomy were recruited from January 2016 to January 2018 (LG: = 567; RG: = 108). A one-to-one propensity score matching (PSM) analysis was applied to minimize the selection bias due to confounding factors, yielding 104 patients in each of the RG and LG groups. After matching, the short-term outcomes and 3-year overall survival were compared in the two groups.
The PSM cohort analysis showed a similar 3-year overall survival between RG and LG groups ( = .249). Concerning the short-term outcomes, the RG compared to LG resulted in lower blood loss ( = .01), lower postoperative complications ( = .001), lower postoperative pain ( = .016), earlier initiation of soft diet ( = .011), shorter hospital stay ( = .012), but higher hospitalization expenses ( = .001).
Our findings suggest that RG may offer advantages in terms of blood loss, surgical complications, recovery time, and pain management compared to LG while maintaining similar overall survival rates. However, RG is associated with higher hospital costs, potentially limiting its wider adoption. Further research, including large, multi-center randomized controlled trials with longer patient follow-up, particularly for advanced gastric cancer, is needed to confirm these findings.
尽管机器人胃切除术(RG)作为治疗胃癌的腹腔镜胃切除术(LG)的替代方法越来越多地被使用,但 RG 相对于 LG 的优势仍存在争议,并且关于两种技术对患者生存的比较研究很少。
在这项回顾性队列研究中,我们从 2016 年 1 月至 2018 年 1 月招募了 675 名接受微创胃切除术的患者(LG:=567;RG:=108)。应用 1:1 倾向评分匹配(PSM)分析来最小化由于混杂因素导致的选择偏差,从而在 RG 和 LG 组中每组各有 104 名患者。匹配后,比较两组的短期结果和 3 年总生存率。
PSM 队列分析显示 RG 和 LG 组 3 年总生存率相似(=0.249)。关于短期结果,与 LG 相比,RG 导致更少的出血量(=0.01)、更少的术后并发症(=0.001)、更少的术后疼痛(=0.016)、更早开始软食(=0.011)、更短的住院时间(=0.012),但住院费用更高(=0.001)。
我们的研究结果表明,与 LG 相比,RG 在出血量、手术并发症、恢复时间和疼痛管理方面可能具有优势,同时保持相似的总生存率。然而,RG 与更高的住院费用相关,可能限制其更广泛的应用。需要进一步的研究,包括具有更长患者随访的大型多中心随机对照试验,特别是针对晚期胃癌,以证实这些发现。